Abstract 4408: Metabolic alterations induced by ibrutinib in CLL cells as a basis for drug combinations to enhance ibrutinib therapeutic activity | NobleID
v1
Abstract 4408: Metabolic alterations induced by ibrutinib in CLL cells as a basis for drug combinations to enhance ibrutinib therapeutic activity
Hélène Pelicano, Feng Li, William G. Wierda, Michael J. Keating, Peng Huang
